Related Experiment Video
Updated: Oct 9, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination
A Patja1, M Paunio, E Kinnunen
1Hospital for Children and Adolescents, Helsinki University Central Hospital, Helsinki, Finland.
Objective:
To assess the postulated causal association between measles-mumps-rubella (MMR) vaccination and Guillain-Barré syndrome (GBS).
Study Design:
Active retrospective study based on linkage of the nationwide hospital discharge register with individual vaccination records. All patients hospitalized for treatment of GBS in Finland between November 1982 and December 1986 were included in the study.
Results:
During the study period, 189 patients were hospitalized for treatment of GBS, and approximately 630,000 vaccine recipients received 900,000 doses of MMR vaccine; 24 of the 189 patients represented the prevailing target population for MMR vaccination, of whom 20 were vaccinated. MMR vaccination did not cause any increase over the background incidence of GBS, and no clustering of cases of GBS occurred at any time point after administration of MMR vaccine. The interval between vaccination and onset of symptoms of GBS exceeded the designated risk period of 6 weeks in all cases, varying from 80 days to years. MMR vaccination after recovery from GBS did not cause relapses of the illness. Respiratory or gastrointestinal tract infection predated the onset of GBS by 3 to 30 days in 20 (83%) of the 24 patients.
Conclusions:
No causal association seems to prevail between MMR vaccination and GBS.
Insights
Measles-mumps-rubella (MMR) vaccination does not cause Guillain-Barré syndrome (GBS). This study found no increased risk or causal link between MMR vaccine and GBS onset in Finnish individuals.
Area of Science:
- Immunology
- Neurology
- Vaccinology
Background:
- Guillain-Barré syndrome (GBS) is a rare neurological disorder.
- The measles-mumps-rubella (MMR) vaccine is widely administered.
- A potential association between MMR vaccination and GBS has been investigated.
Purpose of the Study:
- To investigate the potential causal relationship between MMR vaccination and the incidence of GBS.
- To determine if MMR vaccine administration increases GBS risk.
Main Methods:
- An active retrospective study design was employed.
- Linked nationwide hospital discharge records with individual vaccination data in Finland (1982-1986).
- Included all patients hospitalized for GBS during the study period.
Main Results:
- No increase in GBS incidence was observed following MMR vaccination.
- No temporal clustering of GBS cases occurred after vaccination.
- The time interval between MMR vaccination and GBS onset exceeded the established 6-week risk period in all cases.
- Preceding respiratory or gastrointestinal infections were common before GBS onset.
Conclusions:
- The study found no evidence to support a causal association between MMR vaccination and GBS.
- MMR vaccination does not appear to increase the risk of developing GBS.
More Related Videos
05:44A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
Published on: December 9, 2022
08:13Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
Published on: January 20, 2019
Related Concept Videos
Poliomyelitis
Vaccinations
Diphtheria
Encephalitis l: Introduction
Rocky Mountain Spotted Fever
Respiratory Syncytial Virus Disease